The information highlighted (if any) are the most recent updates for this brand.
Hypersensitivity to olmesartan medoxomil, hydrochlorothiazide or to any of the excipients of Olmesartan Plus, or to other sulphonamide-derived substances (since hydrochlorothiazide is a sulphonamide-derived medicinal product). Severe renal impairment (CrCl <30 mL/min). Refractory hypokalaemia, hypercalcaemia. Cholestasis and biliary obstructive disorders. Pregnancy (2nd and 3rd trimester), lactation.